{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:44:37Z","timestamp":1793159077390,"version":"4.5.0"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.ijbiomac.2025.140462","type":"journal-article","created":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T11:13:08Z","timestamp":1738062788000},"page":"140462","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Development of pyrazolo[1,5-a]pyrimidine-grafted coumarins as selective carbonic anhydrase inhibitors and tubulin polymerization inhibitors with potent anticancer activity"],"prefix":"10.1016","volume":"303","author":[{"given":"Mahmoud S.","family":"Elkotamy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A.","family":"Abdelrahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Giovannuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud Abdelrahman","family":"Alkabbani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Nocentini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wagdy M.","family":"Eldehna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatem A.","family":"Abdel-Aziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar M.","family":"Abou-Seri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.ijbiomac.2025.140462_bb0005","article-title":"Emerging strategies of Cancer therapy based on Ferroptosis","volume":"30","author":"Shen","year":"2018","journal-title":"Adv. Mater."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.140462_bb0010","first-page":"87","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ijbiomac.2025.140462_bb0015","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1039\/D4NA00086B","article-title":"Cutting-edge approaches for targeted drug delivery in breast cancer: beyond conventional therapies","volume":"6","author":"Chaudhari","year":"2024","journal-title":"Nanoscale Advances"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.140462_bb0020","doi-asserted-by":"crossref","DOI":"10.1002\/med.21338","article-title":"Translational horizons in the tumor microenvironment: harnessing breakthroughs and targeting cures","volume":"35","author":"Sun","year":"2015","journal-title":"Med. Res. Rev."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.140462_bb0025","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1158\/1078-0432.CCR-07-1441","article-title":"Therapeutic nanoparticles for drug delivery in Cancer","volume":"14","author":"Cho","year":"2008","journal-title":"Clin. Cancer Res."},{"issue":"19","key":"10.1016\/j.ijbiomac.2025.140462_bb0030","doi-asserted-by":"crossref","first-page":"4680","DOI":"10.1016\/j.biomaterials.2013.03.010","article-title":"Synergistic gene and drug tumor therapy using a chimeric peptide","volume":"34","author":"Han","year":"2013","journal-title":"Biomaterials"},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.140462_bb0035","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1016\/j.bmc.2012.02.014","article-title":"Novel coumarins and 2-thioxo-coumarins as inhibitors of the tumor-associated carbonic anhydrases IX and XII","volume":"20","author":"Carta","year":"2012","journal-title":"Bioorg. Med. Chem."},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.140462_bb0040","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.4155\/fmc.15.71","article-title":"Carbonic anhydrase IX inhibitors in cancer therapy: an update","volume":"7","author":"Supuran","year":"2015","journal-title":"Future Med. Chem."},{"issue":"24","key":"10.1016\/j.ijbiomac.2025.140462_bb0045","doi-asserted-by":"crossref","first-page":"7255","DOI":"10.1016\/j.bmcl.2010.10.094","article-title":"7, 8-Disubstituted-but not 6, 7-disubstituted coumarins selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII over the cytosolic ones I and II in the low nanomolar\/subnanomolar range","volume":"20","author":"Maresca","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.140462_bb0050","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3109\/14756366.2015.1122001","article-title":"How many carbonic anhydrase inhibition mechanisms exist?","volume":"31","author":"Supuran","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"15","key":"10.1016\/j.ijbiomac.2025.140462_bb0055","doi-asserted-by":"crossref","first-page":"10558","DOI":"10.1021\/acs.jmedchem.3c00721","article-title":"1, 5-diaryl-1, 2, 4-triazole ureas as new SLC-0111 analogues endowed with dual carbonic anhydrase and VEGFR-2 inhibitory activities","volume":"66","author":"Elsawi","year":"2023","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.140462_bb0060","doi-asserted-by":"crossref","first-page":"2300449","DOI":"10.1002\/ardp.202300449","article-title":"Identification of 3-(5-cyano-6-oxo-pyridin-2-yl) benzenesulfonamides as novel anticancer agents endowed with EGFR inhibitory activity","volume":"357","author":"Shaldam","year":"2024","journal-title":"Arch. Pharm."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.140462_bb0065","doi-asserted-by":"crossref","first-page":"2201407","DOI":"10.1080\/14756366.2023.2201407","article-title":"Identification of new 4-(6-oxopyridazin-1-yl) benzenesulfonamides as multi-target anti-inflammatory agents targeting carbonic anhydrase, COX-2 and 5-LOX enzymes: synthesis, biological evaluations and modelling insights","volume":"38","author":"Badawi","year":"2023","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.140462_bb0070","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1080\/14756366.2021.2024528","article-title":"Discovery of 2, 4-thiazolidinedione-tethered coumarins as novel selective inhibitors for carbonic anhydrase IX and XII isoforms","volume":"37","author":"Eldehna","year":"2022","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.140462_bb0075","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1080\/14756366.2022.2056734","article-title":"Novel 3-(6-methylpyridin-2-yl) coumarin-based chalcones as selective inhibitors of cancer-related carbonic anhydrases IX and XII endowed with anti-proliferative activity","volume":"37","author":"Tawfik","year":"2022","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.140462_bb0080","doi-asserted-by":"crossref","first-page":"2154603","DOI":"10.1080\/14756366.2022.2154603","article-title":"Discovery of new 6-ureido\/amidocoumarins as highly potent and selective inhibitors for the tumour-relevant carbonic anhydrases IX and XII","volume":"38","author":"El-Damasy","year":"2023","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2025.140462_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104163","article-title":"Recent advancements of coumarin-based anticancer agents: an up-to-date review","volume":"103","author":"Al-Warhi","year":"2020","journal-title":"Bioorg. Chem."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.140462_bb0090","doi-asserted-by":"crossref","first-page":"292","DOI":"10.3109\/14756366.2013.777334","article-title":"Novel coumarins and benzocoumarins acting as isoform-selective inhibitors against the tumor-associated carbonic anhydrase IX","volume":"29","author":"Sharma","year":"2014","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"24","key":"10.1016\/j.ijbiomac.2025.140462_bb0095","doi-asserted-by":"crossref","first-page":"8271","DOI":"10.1021\/jm200983e","article-title":"Glycosyl coumarin carbonic anhydrase IX and XII inhibitors strongly attenuate the growth of primary breast tumors","volume":"54","author":"Touisni","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2025.140462_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112897","article-title":"Novel 3-substituted coumarins as selective human carbonic anhydrase IX and XII inhibitors: synthesis, biological and molecular dynamics analysis","volume":"209","author":"Abdelrahman","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2025.140462_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105888","article-title":"Insights into the effect of elaborating coumarin-based aryl enaminones with sulfonamide or carboxylic acid functionality on carbonic anhydrase inhibitory potency and selectivity","volume":"126","author":"Ibrahim","year":"2022","journal-title":"Bioorg. Chem."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.140462_bb0110","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nrc1317","article-title":"Microtubules as a target for anticancer drugs","volume":"4","author":"Jordan","year":"2004","journal-title":"Nat. Rev. Cancer"},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.140462_bb0115","doi-asserted-by":"crossref","first-page":"7963","DOI":"10.1021\/acs.jmedchem.1c00100","article-title":"Recent progress on tubulin inhibitors with dual targeting capabilities for cancer therapy","volume":"64","author":"Shuai","year":"2021","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.140462_bb0120","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/nrc2803","article-title":"Microtubules and resistance to tubulin-binding agents","volume":"10","author":"Kavallaris","year":"2010","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.140462_bb0125","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3390\/ph13010008","article-title":"Colchicine-binding site inhibitors from chemistry to clinic: a review","volume":"13","author":"McLoughlin","year":"2020","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ijbiomac.2025.140462_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114467","article-title":"Discovery of novel coumarin-indole derivatives as tubulin polymerization inhibitors with potent anti-gastric cancer activities","volume":"238","author":"Song","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2025.140462_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106580","article-title":"Discovery of a novel Coumarin-Dihydroquinoxalone derivative MY-673 as a tubulin polymerization inhibitor capable of inhibiting the ERK pathway with potent anti-gastric cancer activities","volume":"137","author":"Song","year":"2023","journal-title":"Bioorg. Chem."},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.140462_bb0140","doi-asserted-by":"crossref","first-page":"5721","DOI":"10.1021\/acs.jmedchem.6b00158","article-title":"Design, synthesis, and evaluation of in vitro and in vivo anticancer activity of 4-substituted coumarins: a novel class of potent tubulin polymerization inhibitors","volume":"59","author":"Cao","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2025.140462_bb0145","doi-asserted-by":"crossref","unstructured":"S. Combes, P. Barbier, S. Douillard, A. McLeer-Florin, V. Bourgarel-Rey, J.-T. Pierson, A.Y. Fedorov, J.-P. Finet, J. Boutonnat, V. Peyrot, Synthesis and biological evaluation of 4-arylcoumarin analogues of combretastatins. Part 2, Journal of medicinal chemistry 54(9) (2011) 3153\u20133162.","DOI":"10.1021\/jm901826e"},{"key":"10.1016\/j.ijbiomac.2025.140462_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112519","article-title":"Design, synthesis, and bioevaluation of pyrazolo [1, 5-a] pyrimidine derivatives as tubulin polymerization inhibitors targeting the colchicine binding site with potent anticancer activities","volume":"202","author":"Li","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2025.140462_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105220","article-title":"Design, synthesis and bioevaluation of 2, 7-diaryl-pyrazolo [1, 5-a] pyrimidines as tubulin polymerization inhibitors","volume":"115","author":"Liu","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ijbiomac.2025.140462_bb0160","article-title":"Mitigating the resistance of MCF-7 cancer cells to doxorubicin under hypoxic conditions with novel coumarin based carbonic anhydrase IX and XII inhibitors","volume":"107759","author":"Abdelaal","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ijbiomac.2025.140462_bb0165","article-title":"Discovery of new sulfonamide-tethered 2-aryl-4-anilinoquinazolines as the first-in-class dual carbonic anhydrase and EGFR inhibitors","volume":"135010","author":"Eldehna","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.140462_bb0170","doi-asserted-by":"crossref","first-page":"2300599","DOI":"10.1002\/ardp.202300599","article-title":"Phthalimide-tethered isatins as novel poly (ADP-ribose) polymerase inhibitors: design, synthesis, biological evaluations, and molecular modeling investigations","volume":"357","author":"El Hassab","year":"2024","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.ijbiomac.2025.140462_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.107037","article-title":"Identification of novel ureido benzothiophenes as dual VEGFR-2\/EGFR anticancer agents","volume":"143","author":"Eldehna","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ijbiomac.2025.140462_bb0180","article-title":"Development of new LSM-83177 analogues as anti-tumor agents against colorectal cancer targeting p53-MDM2 interaction","volume":"107766","author":"Elgohary","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ijbiomac.2025.140462_bb0185","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.bioorg.2017.08.014","article-title":"Pyrazole-hydrazone derivatives as anti-inflammatory agents: design, synthesis, biological evaluation, COX-1, 2\/5-LOX inhibition and docking study","volume":"74","author":"Abdelgawad","year":"2017","journal-title":"Bioorg. Chem."},{"issue":"22","key":"10.1016\/j.ijbiomac.2025.140462_bb0190","doi-asserted-by":"crossref","first-page":"6500","DOI":"10.1021\/jm0605740","article-title":"4-Arylazo-3, 5-diamino-1 H-pyrazole CDK inhibitors: SAR study, crystal structure in complex with CDK2, selectivity, and cellular effects","volume":"49","author":"Kry\u0161tof","year":"2006","journal-title":"J. Med. Chem."},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.140462_bb0195","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1039\/D1MD00275A","article-title":"SAR study of 4-arylazo-3, 5-diamino-1 H-pyrazoles: identification of small molecules that induce dispersal of Pseudomonas aeruginosa biofilms","volume":"12","author":"Jansen","year":"2021","journal-title":"RSC Medicinal Chemistry"},{"key":"10.1016\/j.ijbiomac.2025.140462_bb0200","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.ejmech.2016.10.020","article-title":"Analogue based drug design, synthesis, molecular docking and anticancer evaluation of novel chromene sulfonamide hybrids as aromatase inhibitors and apoptosis enhancers","volume":"124","author":"Ghorab","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2025.140462_bb0205","doi-asserted-by":"crossref","unstructured":"K. RA Abdellatif, M. A Abdelgawad, H. AH Elshemy, N. M Kahk, D. M El Amir, Design, synthesis, antioxidant and anticancer activity of new coumarin derivatives linked with thiazole, isoxazole or pyrazole moiety, Lett. Drug Des. Discovery 14(7) (2017) 773\u2013781.","DOI":"10.2174\/1570180813666161026153743"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.140462_bb0210","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.bpj.2020.11.011","article-title":"Response to perspectives on the classical enzyme carbonic anhydrase and the search for inhibitors","volume":"120","author":"Angeli","year":"2021","journal-title":"Biophys. J."},{"key":"10.1016\/j.ijbiomac.2025.140462_bb0215","doi-asserted-by":"crossref","unstructured":"G.L. Almajan, A. Innocenti, L. Puccetti, G. Manole, S. Barbuceanu, I. Saramet, A. Scozzafava, C.T. Supuran, Carbonic anhydrase inhibitors. Inhibition of the cytosolic and tumor-associated carbonic anhydrase isozymes I, II, and IX with a series of 1, 3, 4-thiadiazole-and 1, 2, 4-triazole-thiols, Bioorganic & medicinal chemistry letters 15(9) (2005) 2347\u20132352.","DOI":"10.1016\/j.bmcl.2005.02.088"},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.140462_bb0220","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/jnci\/83.11.757","article-title":"Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines","volume":"83","author":"Monks","year":"1991","journal-title":"JNCI J. Natl. Cancer Inst."},{"issue":"13","key":"10.1016\/j.ijbiomac.2025.140462_bb0225","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/jnci\/82.13.1107","article-title":"New colorimetric cytotoxicity assay for anticancer-drug screening","volume":"82","author":"Skehan","year":"1990","journal-title":"JNCI: Journal of the National Cancer Institute"},{"issue":"14","key":"10.1016\/j.ijbiomac.2025.140462_bb0230","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1021\/jm00040a010","article-title":"Anticancer specificity of some ellipticinium salts against human brain tumors in vitro","volume":"37","author":"Acton","year":"1994","journal-title":"J. Med. Chem."},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.140462_bb0235","first-page":"1527","article-title":"Design, synthesis, and biological evaluation of novel 5, 6, 7-trimethoxy quinolines as potential anticancer agents and tubulin polymerization inhibitors","volume":"23","author":"Mirzaei","year":"2020","journal-title":"Iran. J. Basic Med. Sci."},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.140462_bb0240","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1248\/cpb.c20-00575","article-title":"Design, synthesis and biological evaluation of novel 4-(4-methoxynaphthalen-1-yl)-5-arylpyrimidin-2-amines as tubulin polymerization inhibitors","volume":"68","author":"Liu","year":"2020","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.ijbiomac.2025.140462_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.140579","article-title":"Exploring antitumor activity of novel imidazo [2, 1-b] thiazole and imidazo [1, 2-a] pyridine derivatives on MDA-MB-231 cell line: targeting VEGFR-2 enzyme with computational insight","volume":"1322","author":"Elgohary","year":"2025","journal-title":"J. Mol. Struct."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.140462_bb0250","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/s41419-018-0476-2","article-title":"Inhibition of cancer progression by a novel trans-stilbene derivative through disruption of microtubule dynamics, driving G2\/M arrest, and p53-dependent apoptosis","volume":"9","author":"Parida","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ijbiomac.2025.140462_bb0255","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1007\/BF02978210","article-title":"Adiponectin induces growth arrest and apoptosis of MDA-MB-231 breast cancer cell","volume":"28","author":"Kang","year":"2005","journal-title":"Arch. Pharm. Res."},{"issue":"19","key":"10.1016\/j.ijbiomac.2025.140462_bb0260","doi-asserted-by":"crossref","first-page":"4895","DOI":"10.3390\/cancers13194895","article-title":"Evolution of the tumor microenvironment toward immune-suppressive seclusion during brain metastasis of breast cancer: implications for targeted therapy","volume":"13","author":"Noh","year":"2021","journal-title":"Cancers"},{"issue":"55","key":"10.1016\/j.ijbiomac.2025.140462_bb0265","doi-asserted-by":"crossref","first-page":"7305","DOI":"10.1038\/sj.onc.1209735","article-title":"Mutant p53 in MDA-MB-231 breast cancer cells is stabilized by elevated phospholipase D activity and contributes to survival signals generated by phospholipase D","volume":"25","author":"Hui","year":"2006","journal-title":"Oncogene"},{"issue":"21","key":"10.1016\/j.ijbiomac.2025.140462_bb0270","doi-asserted-by":"crossref","first-page":"11357","DOI":"10.1073\/pnas.94.21.11357","article-title":"Comparison of the ion channel characteristics of proapoptotic BAX and antiapoptotic BCL-2","volume":"94","author":"Schlesinger","year":"1997","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"16","key":"10.1016\/j.ijbiomac.2025.140462_bb0275","doi-asserted-by":"crossref","first-page":"8927","DOI":"10.3390\/ijms22168927","article-title":"The duality of caspases in cancer, as told through the fly","volume":"22","author":"Hounsell","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"22","key":"10.1016\/j.ijbiomac.2025.140462_bb0280","doi-asserted-by":"crossref","first-page":"9004","DOI":"10.1021\/acs.jmedchem.5b01343","article-title":"Efficient expression and crystallization system of cancer-associated carbonic anhydrase isoform IX","volume":"58","author":"Leitans","year":"2015","journal-title":"J. Med. Chem."},{"issue":"17","key":"10.1016\/j.ijbiomac.2025.140462_bb0285","doi-asserted-by":"crossref","first-page":"9545","DOI":"10.1073\/pnas.161301298","article-title":"Crystal structure of the dimeric extracellular domain of human carbonic anhydrase XII, a bitopic membrane protein overexpressed in certain cancer tumor cells","volume":"98","author":"Whittington","year":"2001","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"6979","key":"10.1016\/j.ijbiomac.2025.140462_bb0290","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/nature02393","article-title":"Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain","volume":"428","author":"Ravelli","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2025.140462_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.137554","article-title":"Spiro-fused indoline-quinazoline hybrids as smart bombs against TNF-\u03b1-mediated inflammation","volume":"283","author":"Elkotamy","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2025.140462_bb0300","article-title":"Design, synthesis, and evaluation of novel Benzofuran and Pyrazole-based derivatives as dual AChE\/BuChE inhibitors with antioxidant properties for Alzheimer\u2019s disease management","volume":"117158","author":"Elkotamy","year":"2024","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.140462_bb0305","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.140462_bb0310","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1021\/ci800305f","article-title":"OSIRIS, an entirely in-house developed drug discovery informatics system","volume":"49","author":"Sander","year":"2009","journal-title":"J. Chem. Inf. Model."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.140462_bb0315","doi-asserted-by":"crossref","DOI":"10.1002\/ddr.70009","article-title":"Molecular docking, DFT and antiproliferative properties of 4-(3, 4-dimethoxyphenyl)\u2212 3-(4-methoxyphenyl)\u2212 1-phenyl-1H-pyrazolo [3, 4-b] pyridine as potent anticancer agent with CDK2 and PIM1 inhibition potency","volume":"85","author":"Binjubair","year":"2024","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.ijbiomac.2025.140462_bb0320","first-page":"gkae303","article-title":"ProTox 3.0: a webserver for the prediction of toxicity of chemicals","author":"Banerjee","year":"2024","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.140462_bb0325","doi-asserted-by":"crossref","first-page":"739","DOI":"10.3390\/molecules24040739","article-title":"Synthesis and biological evaluation of novel thiazolyl-coumarin derivatives as potent histone deacetylase inhibitors with antifibrotic activity","volume":"24","author":"Pardo-Jim\u00e9nez","year":"2019","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.140462_bb0330","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1080\/14756366.2022.2124409","article-title":"Design and synthesis of benzothiazole-based SLC-0111 analogues as new inhibitors for the cancer-associated carbonic anhydrase isoforms IX and XII","volume":"37","author":"Al-Warhi","year":"2022","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2025.140462_bb0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115538","article-title":"Design and synthesis of 6-arylpyridine-tethered sulfonamides as novel selective inhibitors of carbonic anhydrase IX with promising antitumor features toward the human colorectal cancer","volume":"258","author":"Eldehna","year":"2023","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.140462_bb0340","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1021\/acs.jmedchem.3c02279","article-title":"Discovery of novel pyridazine-tethered sulfonamides as carbonic anhydrase II inhibitors for the management of glaucoma","volume":"67","author":"Tawfik","year":"2024","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.140462_bb0345","doi-asserted-by":"crossref","first-page":"2191163","DOI":"10.1080\/14756366.2023.2191163","article-title":"Development of novel anilinoquinazoline-based carboxylic acids as non-classical carbonic anhydrase IX and XII inhibitors","volume":"38","author":"Elsayed","year":"2023","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2025.140462_bb0350","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ejmech.2015.10.053","article-title":"1-Piperazinylphthalazines as potential VEGFR-2 inhibitors and anticancer agents: synthesis and in vitro biological evaluation","volume":"107","author":"Abou-Seri","year":"2016","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.140462_bb0355","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3390\/ph17020216","article-title":"Design, synthesis and biological assessment of N\u2032-(2-Oxoindolin-3-ylidene)-6-methylimidazo [2, 1-b] thiazole-5-carbohydrazides as potential anti-proliferative agents toward MCF-7 breast Cancer","volume":"17","author":"Alshaye","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ijbiomac.2025.140462_bb0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107644","article-title":"Novel imidazo [2, 1-b] thiazoles and imidazo [1, 2-a] pyridines tethered with indolinone motif as VEGFR-2 inhibitors and apoptotic inducers: design, synthesis and biological evaluations","volume":"151","author":"Elkotamy","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ijbiomac.2025.140462_bb0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104141","article-title":"Design, synthesis, molecular modeling, and biological evaluation of pyrazole-naphthalene derivatives as potential anticancer agents on MCF-7 breast cancer cells by inhibiting tubulin polymerization","volume":"103","author":"Wang","year":"2020","journal-title":"Bioorg. Chem."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025010116?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025010116?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T09:45:03Z","timestamp":1782899103000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813025010116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":73,"alternative-id":["S0141813025010116"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.140462","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of pyrazolo[1,5-a]pyrimidine-grafted coumarins as selective carbonic anhydrase inhibitors and tubulin polymerization inhibitors with potent anticancer activity","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.140462","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"140462"}}